Feeding the Tiniest Babies Through a Vein: Why "More Protein" Is Not Always Better

What a New Zealand study of first-week nutrition tells families about the balance of protein and fat for very premature newborns

When a baby is born extremely early, weighing less than a bag of sugar, the tiny stomach and intestines are not ready to handle milk, so nourishment has to be delivered straight into the bloodstream through a thin tube. For years, doctors believed that giving these babies plenty of protein right away would protect their growing brains and bodies. A large study from New Zealand now suggests the picture is more subtle: it is not simply how much protein a baby receives in the first week that matters, but which building blocks of protein are given — and that generous early fat may quietly help rather than harm.

The building blocks of protein are called amino acids, and the intravenous nutrition given to premature babies is essentially a carefully mixed liquid of amino acids, fat, sugar, vitamins, and minerals. The study looked closely at how the exact amounts of these amino acids and fat in a baby's first week lined up with later health problems and with the child's development at age two [1].

This kind of intravenous feeding is not a minor detail of newborn care; for the smallest babies it is the main source of nourishment for days or even weeks, given while the digestive system slowly matures enough to handle milk. Getting the recipe right is genuinely difficult, because a baby born four months early is growing faster than at any other moment of life and yet has organs — liver, kidneys, gut — that are still forming and can be easily overwhelmed. That tension, between feeding a rapidly growing baby and not overloading an immature body, is exactly what this research set out to understand better.

Why this question matters so much to families

Babies born extremely early — those weighing under 1000 grams, around two pounds — now survive far more often than they did decades ago, which is a genuine triumph of modern newborn care. But surviving is only the beginning. Many of these children still face serious complications of prematurity, including chronic lung disease that can mean months of breathing support, bleeding in the brain, an eye condition that can threaten vision, and dangerous infections [2]. These early problems can leave lasting marks, shaping how a child breathes, moves, and learns for years to come [3]. Because nutrition is one of the few things doctors can adjust in those first crucial days, researchers have long hoped that feeding these babies better — and especially giving them more protein sooner — might improve their futures. Earlier studies had shown that babies who received more energy and protein early on tended to grow and develop better, which seemed to confirm the idea [4].

How "give more protein, quickly" became the norm — and then wobbled

Over time, "start protein early and build up fast" became standard practice in newborn intensive care units around the world, and international expert guidelines recommended fairly high early amounts of amino acids [5]. But the proof that this actually helped babies in the long run was never solid. When researchers pooled the available trials, they could not confirm a lasting benefit, and they warned that a very premature baby's immature body might simply be unable to handle a big load of amino acids in the first days of life [6].

The turning point came from a carefully designed New Zealand and Australian study called the ProVIDe trial. In this trial, extremely small babies were randomly given either a little extra protein or a dummy solution during their first five days, and neither the families nor the doctors knew which each baby received until the study ended. The result surprised many: the babies who got the extra early protein did not do better at age two, and if anything the hints pointed the wrong way [7]. That finding raised a new question. If giving more total protein does not help, could the answer lie in the specific mix of amino acids being given? The study described here was designed to explore exactly that.

What the researchers did

The researchers followed 382 of these extremely small babies who were cared for in six New Zealand hospitals [1]. Instead of comparing the two random groups again, they took a closer look at every baby individually: they worked out precisely how much of each amino acid and how much fat each baby actually received in the first week, and they used the routine "heel-prick" newborn screening blood cards — the same simple blood spots collected from almost every newborn — to measure the amino acid levels in each baby's blood [1]. Then they compared all of this to the babies' medical complications and to their development, measured with standard tests, at two years of age [1]. On average the babies were born at about 26 weeks of pregnancy and weighed 782 grams; 294 of them were assessed at age two [1].

What they found: not all amino acids behave the same

The most striking discovery was that different amino acids seemed to pull in different directions. Babies who received the most of an amino acid called tyrosine were more than twice as likely to develop chronic lung disease, and a similar pattern appeared for another amino acid, proline [1]. Yet a different amino acid, cysteine, seemed protective — babies who got the most of it had only about half the risk of chronic lung disease [1]. The same split showed up for infection: higher amounts of some amino acids lined up with more suspected infections, while others, cysteine especially, lined up with fewer [1].

The researchers are careful to point out an important subtlety. Many of these "infections" were suspected rather than proven by a laboratory test, and some may not have been infections at all but a different problem called refeeding syndrome — a chemical imbalance in the blood that can happen when nutrition is increased too quickly, which the same group of babies had shown before [8]. In other words, a baby given a lot of protein who then looked unwell might sometimes have been reacting to the nutrition itself rather than to germs [8]. This fits with a longstanding concern that the standard amino acid mixtures given to premature babies were never really tailored to their unique needs — supplying too much of some building blocks and too little of others, like tyrosine and cysteine [9].

Fat, it turns out, may be a quiet helper

One of the most encouraging findings concerned fat. Babies who received more fat in their intravenous nutrition during the first week had noticeably lower risks of bleeding in the brain, chronic lung disease, and the eye condition of prematurity [1]. This runs against an older worry that fat had to be given cautiously, and it supports current guidance that allows premature babies to receive generous fat early on — as long as their blood minerals, especially phosphate, are watched and topped up to prevent the imbalance mentioned above [1][10]. The particular brand of nutrition mattered too, with different products linked to different risks, which tells doctors that the exact recipe, not just the amount, deserves attention [1].

The reassuring news about development

Perhaps the most comforting finding for parents is what the study did not find. None of the first-week amino acid measurements — not the amounts given, not the levels in the blood — were linked to how the children were developing at age two [1]. This lines up with the earlier ProVIDe result and means that choosing a more measured, careful approach to early protein is not the same as depriving a baby's brain [1][7]. Families can take real reassurance that a thoughtful, moderate feeding plan is not a compromise on their child's future.

What this means, and what comes next

It is important to be clear about what this kind of study can and cannot say. Because the researchers observed what happened rather than deliberately changing each baby's diet, the results show connections, not proof of cause and effect, and the researchers themselves describe their findings as early clues that need further testing [1]. Still, the direction is thought-provoking. The old question — "how quickly can we get a baby to full protein?" — is giving way to a better one: "which building blocks, in what balance, alongside how much fat?" [1][6][9]. Answering it will take new trials that test different recipes rather than just different amounts, and earlier efforts such as the Nutritional Evaluation and Optimisation in Neonates (NEON) trial in the United Kingdom show both how valuable and how challenging that work is [11]. For now, families can know that the teams caring for the smallest babies are actively rethinking a long-held habit — leaning toward a careful, balanced approach to protein, making good use of early fat, and keeping a close eye on the delicate chemistry of a newborn who is growing faster than at any other time in life.

References

  1. Cormack BE, van Duinen A, Ford N, Jiang Y, de Hora M, Heather N, Bloomfield FH. Early Nutrition, Blood Amino Acids and Outcomes in Preterm Babies: Secondary Cohort Analysis of the ProVIDe RCT. Nutrients. 2026;18(10):1517. doi:10.3390/nu18101517 ↩
  2. Siffel C, Hirst AK, Sarda SP, Kuzniewicz MW, Li DK. The clinical burden of extremely preterm birth in a large medical records database in the United States: mortality and survival associated with selected complications. Early Hum Dev. 2022;171:105613. doi:10.1016/j.earlhumdev.2022.105613 ↩
  3. Morniroli D, Tiraferri V, Maiocco G, De Rose DU, Cresi F, Coscia A, Mosca F, Giannì ML. Beyond survival: the lasting effects of premature birth. Front Pediatr. 2023;11:1213243. doi:10.3389/fped.2023.1213243 ↩
  4. Ehrenkranz RA, Das A, Wrage LA, Poindexter BB, Higgins RD, Stoll BJ, Oh W. Early nutrition mediates the influence of severity of illness on extremely low birth weight infants. Pediatr Res. 2011;69:522–529. doi:10.1203/PDR.0b013e318217f4f1 ↩
  5. van Goudoever JB, Carnielli V, Darmaun D, Sainz de Pipaón M; ESPGHAN/ESPEN/ESPR/CSPEN working group. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Amino acids. Clin Nutr. 2018;37(6 Pt B):2315–2323. doi:10.1016/j.clnu.2018.06.945 ↩
  6. Osborn DA, et al. Higher versus lower amino acid intake in parenteral nutrition for newborn infants. Cochrane Database Syst Rev. 2018;3:CD005949. doi:10.1002/14651858.CD005949.pub2 ↩
  7. Bloomfield FH, Jiang Y, Harding JE, Crowther CA, Cormack BE; ProVIDe Trial Group. Early Amino Acids in Extremely Preterm Infants and Neurodisability at 2 Years. N Engl J Med. 2022;387(18):1661–1672. doi:10.1056/NEJMoa2204886 ↩
  8. Cormack BE, Jiang Y, Harding JE, Crowther CA, Bloomfield FH. Neonatal Refeeding Syndrome and Clinical Outcome in Extremely Low-Birth-Weight Babies: Secondary Cohort Analysis From the ProVIDe Trial. JPEN J Parenter Enteral Nutr. 2021;45(1):65–78. doi:10.1002/jpen.1934 ↩
  9. Prolla IRD, Tomlinson C, Pencharz PB, Porto B, Elango R, Courtney-Martin G. Amino acid requirements of total parenteral nutrition (TPN) fed neonates: a narrative review of current knowledge and the basis for a new amino acid solution in neonatal nutrition. Pediatr Med. 2021;5:29. doi:10.21037/pm-21-27 ↩
  10. Jochum F, Moltu SJ, Senterre T, Nomayo A, Goulet O, Iacobelli S; ESPGHAN/ESPEN/ESPR/CSPEN working group. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Fluid and electrolytes. Clin Nutr. 2018;37(6 Pt B):2344–2353. doi:10.1016/j.clnu.2018.06.948 ↩
  11. Uthaya S, et al. Nutritional Evaluation and Optimisation in Neonates (NEON): a randomised double-blind controlled trial of amino acid regimen and intravenous lipid composition in preterm parenteral nutrition. Efficacy Mech Eval. 2016;3(2). doi:10.3310/eme03020 ↩